A 32-year-old male from rural Maharashtra presents to the emergency department with a 5-day history of progressive weakness starting in both lower limbs and ascending to involve the upper limbs and face. He reports a viral illness with diarrhea 2 weeks prior. On examination, he has symmetrical flaccid paralysis of lower limbs, diminished deep tendon reflexes, and mild facial weakness. Vital signs show respiratory rate 28/min, blood pressure 140/90 mmHg, and heart rate 102/min with occasional irregular beats. CSF analysis shows protein 85 mg/dL with normal cell count. Nerve conduction studies show prolonged distal latencies and conduction blocks. What is the most appropriate immediate management?

Explanation

## Diagnosis and Clinical Reasoning **Key Point:** This patient has Guillain-Barré Syndrome (GBS) — specifically the demyelinating variant (AIDP) — with autonomic involvement. Both IVIG and plasma exchange are first-line treatments of equal efficacy; however, IVIG (option D) is the preferred first-line choice in most Indian and global guidelines due to practical and safety advantages. ## Why This Is GBS (AIDP) | Feature | This Patient | |---|---| | Ascending symmetrical flaccid paralysis | ✓ Lower limbs → upper limbs → face | | Hyporeflexia/areflexia | ✓ Diminished DTRs | | Antecedent infection | ✓ Viral diarrhea 2 weeks prior | | Albuminocytologic dissociation | ✓ Protein 85 mg/dL, normal cell count | | Demyelinating NCS pattern | ✓ Prolonged distal latencies, conduction blocks | | Autonomic dysfunction | ✓ Hypertension, tachycardia, arrhythmia | ## Treatment Decision Both **IVIG** and **Plasma Exchange (PLEX)** are Class I evidence, Grade A recommendations for GBS (Harrison's 21e, Ch. 385). They are equally efficacious when started within **2 weeks** of symptom onset. Combining them confers no additional benefit. **Why IVIG is preferred over Plasma Exchange in this context:** 1. **Ease of administration:** IVIG requires only peripheral IV access; PLEX requires central venous catheterization — a significant procedural burden in emergency/resource-limited settings. 2. **Safety profile:** IVIG avoids risks of coagulopathy, hypocalcemia, and hemodynamic instability associated with PLEX — particularly important given this patient's autonomic instability (arrhythmia, labile BP). 3. **Speed:** IVIG is administered over 3–5 days vs. 5 sessions over 7–10 days for PLEX. 4. **NEET PG/NBE emphasis:** Indian postgraduate curricula (as per standard textbooks and NBE model papers) consistently list IVIG as the preferred first-line agent in GBS, with PLEX as an equally valid alternative when IVIG is unavailable or contraindicated (e.g., IgA deficiency, renal failure). **High-Yield:** Plasma exchange is NOT wrong — it is equally effective — but IVIG is the preferred answer in exam settings when both are listed as options, unless a specific contraindication to IVIG is mentioned. ## Why Other Options Are Wrong - **Option B (Mechanical ventilation + observation):** Respiratory support is essential adjunct care (RR 28/min warrants monitoring for impending respiratory failure), but it is NOT the primary immunomodulatory therapy. "Observation" alone is inappropriate when disease-modifying treatment is available. - **Option C (Corticosteroids):** Steroids are **contraindicated** in GBS. Multiple RCTs (including the Dutch GBS trial) have shown corticosteroids do not improve outcomes and may prolong time to recovery. This is a classic NEET PG trap. ## Autonomic Dysfunction — ICU Imperative **Clinical Pearl:** Autonomic instability (hypertension, tachycardia, arrhythmia) is a life-threatening complication of GBS requiring continuous cardiac monitoring in the ICU. However, autonomic dysfunction does not change the choice of immunotherapy — IVIG remains first-line. **Mnemonic:** In GBS — **"I**mmunoglobulin **G**oes **B**efore **S**teroids (which are contraindicated)" [cite: Harrison's Principles of Internal Medicine, 21e, Ch. 385; KD Tripathi Essentials of Medical Pharmacology, 8e]